Pet Stem Cells Market Set to Reach $550 Million by 2030 | Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Global Pet Stem Cells Market.
The Pet Stem Cells Market is projected to grow from $125 million in 2023 to $550 million by 2030, reflecting a compound annual growth rate (CAGR) of 21.5%.
Stem cells have the ability to develop into various tissues, including blood vessels, bone, heart, cartilage, fat, ligaments, liver, muscle, nerves, and tendons. They can be sourced from the bone marrow and fat tissues of dogs, cats, and horses. The most prevalent application of stem cell therapy is in treating osteoarthritis in pets. Additionally, stem cells show promise for repairing bone, ligament, and spinal cord injuries, as well as addressing kidney and liver diseases, cardiomyopathy, and certain inflammatory conditions affecting the skin and intestine. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization.
Download a Sample Report - https://exactitudeconsultancy.com/reports/32841/pet-stem-cells-market/#request-a-sample
Competitive Landscape provides the Industry developments such as new product launches, expansion, mergers & acquisitions, partnerships, agreements, joint ventures, business overview, key strategies and financial analysis associated with the key players. Strategy implemented to overcome the COVID-19 Impact, Ukrainian war, Israel war, China USA geopolitical situation, and other key geopolitical events will be discussed in the report scope. Key Vendors Financials includes Revenue (USD Million), Gross Margin (XX%) and Market Share (XX%) (2024- 2030), S.W.O.T Analysis, (To read more request the sample pages or speak to analyst/author directly Contact).
Key Company by Region Wise:
North America
- VetStem Biopharma (USA)
- Arthrex (USA)
Asia-Pacific
- GST (Boehringer Ingelheim) (China)
- EquiCord (China)
- Taiwan Pet Valley Advance Biotech Co., Ltd (Taiwan)
- Tianjin Bion Medical (China)
- Kyon Pharmaceuticals (Australia)
Australia
- Regeneus (Australia)
Global
- Boyalife (China, with global operations)
- AVSC (part of various global operations)
Europe
- StemCells, Inc. (USA, but involved in global markets)
Notable Mentions
- Vetbiologics (may operate in various regions, specifics depend on local operations)
Browse a full Report- https://exactitudeconsultancy.com/reports/32841/pet-stem-cells-market/
Recent developments include:
- VetStem Biopharma has recently expanded its FDA-approved treatments for canine osteoarthritis and is exploring new applications for cats and horses.
- Gallant has introduced new stem cell storage plans and has expanded its cryopreservation services to support long-term stem cell banking for various pet species.
- MediVet Biologics has released its next-generation autologous stem cell kits, enabling veterinary clinics to offer more efficient and cost-effective stem cell therapies for pets
Market by Type
Bone Marrow Stem Cells
Adipose Stem Cell
Others
Market by Application
Osteoarthritis Disease
Immunomodulatory Diseases
Others
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 169 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $125 million |
| Forecasted Market Value (USD) by 2030 | $550 million |
| Compound Annual Growth Rate | 21.5% |
| Regions Covered | Global |
Download a Sample Report -
https://exactitudeconsultancy.com/reports/32841/pet-stem-cells-market/#request-a-sample
Regional Analysis:
North America accounted for the largest market in the pet stem cells market. North America accounted for the 40% market share of the global market value. It has a sizable market share in North America due to the strong demand for treatment. Due to the enormous number of pet owners and the increased government financing for animal health, which is reviving the industry, animal stem cell treatment is in great demand in North America. The market for pet stem cells is growing in North America because to the increased need for innovative veterinary treatments. Dogs in the neighborhood may have better lives thanks to stem cell therapy, especially those with age-related and orthopedic conditions. This awareness is growing among pet owners. Favorable governmental actions and financial commitments to R&D can support market expansion.
The market for pet stem cells in Europe is expanding quickly and has a lot of promise. The market was expanding significantly, propelled by increased pet owners’ knowledge of the advantages of stem cell treatment and a rising propensity for cutting-edge veterinary care. The market was growing as a result of the area’s developed veterinary infrastructure, favorable regulatory climate, and continuous research initiatives. Advancements in the sector were also being facilitated through partnerships between academic institutions, business leaders, and veterinary experts.
Conclusion:
The increasing adoption of pet stem cell therapies is revolutionizing the veterinary industry, offering pet owners effective treatments for chronic and degenerative conditions. As innovations in stem cell banking, cryopreservation, and FDA-approved therapies continue to develop, the market is poised for sustained growth. The pet stem cell market is evolving rapidly, with companies continuously innovating to offer new treatments and improve existing ones. As stem cell therapies gain wider adoption and technological advancements make treatments more accessible, the market is positioned for continued growth, benefiting both pets and their owners.
Find More Research:
Charcot-Marie-Tooth Disease Market - https://exactitudeconsultancy.com/reports/34975/charcot-marie-tooth-disease-market/
The global Charcot-Marie-Tooth Disease market is anticipated to grow from USD 1.22 Billion in 2024 to USD 5.50 Billion by 2030, at a CAGR of 24 % during the forecast period.
Marine-derived Pharmaceuticals Market - https://exactitudeconsultancy.com/reports/32945/marine-derived-pharmaceuticals-market/
The global Marine-derived pharmaceuticals market is anticipated to grow from USD 2,922.11 Million in 2023 to USD 5,341.16 Million by 2030, at a CAGR of 9.0 % during the forecast period.
Pharmaceutical Contract Development and Manufacturing Market - https://exactitudeconsultancy.com/reports/31181/pharmaceutical-contract-development-and-manufacturing-market/
The global pharmaceutical contract development and manufacturing market size was valued at USD 208.72 billion in 2023, and projected to reach USD 343.81 billion by 2030, with a CAGR of 7.39% from 2023 to 2030.
Neuroscience Antibodies & Assays Market-https://exactitudeconsultancy.com/reports/30511/neuroscience-antibodies-assays-market/
Neuroscience antibodies & assays market is expected to grow at 10.3% CAGR from 2023 To 2030. It was valued 4.23 billion at 2023. It is expected to reach above USD 8.40 billion by 2030.
Preclinical Imaging (In-VIVO) Market - https://exactitudeconsultancy.com/reports/30507/preclinical-imaging-market-2/
The preclinical imaging (in-vivo) market is expected to grow at 5.85% CAGR from 2023 to 2030. It is expected to reach above USD 1345.93 Million by 2030 from USD 927.43 Million in 2023.
Molecular Weight Marker Market - https://exactitudeconsultancy.com/reports/30466/molecular-weight-marker-market/
The molecular weight marker market is expected to grow at 12.1% CAGR from 2023 To 2030. It was valued 422 million in 2023. It is expected to reach above USD 938.76 million by 2030.
Metabolomics Market - https://exactitudeconsultancy.com/reports/30429/metabolomics-market/
The global metabolomics market is expected to grow at 14% CAGR from 2023 to 2030. It is expected to reach above USD 7.13 billion by 2030 from USD 2.9 billion in 2023.
miRNA Sequencing and Assay Market - https://exactitudeconsultancy.com/reports/30394/mirna-sequencing-and-assay-market/
The miRNA sequencing and assay market is expected to grow at 13.61% CAGR from 2023 To 2030. It is expected to reach above USD 778.83 Million by 2030 from USD 318.80 Million in 2023.
Metabolic Testing Market - https://exactitudeconsultancy.com/reports/30406/metabolic-testing-market/
The global metabolic testing market is projected to reach USD 731.16 million by 2030 from USD 440.71 million in 2023, at a CAGR of 8.3 % from 2023 to 2030
Human Liver Models Market - https://exactitudeconsultancy.com/reports/30377/human-liver-models-market/
The global Human Liver Models Market is expected to grow at more than 12.66% CAGR from 2023 to 2030. It is expected to reach above USD 4.88 billion by 2030 from a little above USD 2.12 billion in 2023.
Fill Finish Manufacturing Market - https://exactitudeconsultancy.com/reports/30252/fill-finish-manufacturing-market/
The Fill Finish Manufacturing Market is expected to grow at 9.33 % CAGR from 2023 to 2030. It is expected to reach above USD 20.43 Billion by 2030 from USD 10.94 Billion in 2023.
Forensic Equipment and Supplies Market - https://exactitudeconsultancy.com/reports/30234/forensic-equipment-and-supplies-market/
The global forensic equipment and supplies market is projected to reach USD 14.76 billion by 2030 from USD 8.67 billion in 2023, at a CAGR of 7.9 % from 2023 to 2030.
Chromatography Instruments Market - https://exactitudeconsultancy.com/reports/30155/chromatography-instruments-market/
The chromatography instruments market is expected to grow at 6.6 % CAGR from 2023 to 2030. It is expected to reach above USD 16.3 billion by 2030 from USD 10.42 billion in 2023
Elemental Analysis Market - https://exactitudeconsultancy.com/reports/30166/elemental-analysis-market/
The elemental analysis market is expected to grow at 6.30% CAGR from 2023 to 2030. It is expected to reach above USD 2.82 billion by 2030 from USD 1.84 billion in 2023.
Bed Monitoring System & Baby Monitoring System Market - https://exactitudeconsultancy.com/reports/30051/bed-monitoring-system-baby-monitoring-system-market/
The bed monitoring system & baby monitoring system market is expected to grow at 7.85 % CAGR from 2023 to 2030. It is expected to reach above USD 2.98 billion by 2030 from USD 1.76 billion in 2023.
Atrial Fibrillation Surgery Market - https://exactitudeconsultancy.com/reports/30018/atrial-fibrillation-surgery-market/
The Atrial Fibrillation Surgery Market is expected to grow at 13.8% CAGR from 2023 to 2030. It is expected to reach above USD 5.12 billion by 2030 from USD 1.82 billion in 2023.
Epigenetics Market - https://exactitudeconsultancy.com/reports/30029/epigenetics-market/
The epigenetics market is expected to grow at 16.7% CAGR from 2023 to 2030. It is expected to reach above USD 16.63 Billion by 2030 from USD 5.64 Billion in 2023.
Biobanking Market - https://exactitudeconsultancy.com/reports/29990/biobanking-market/
The Biobanking market is expected to grow at 7.9% CAGR from 2023 to 2030. It is expected to reach above USD 48.33 billion by 2030 from USD 28.80 billion in 2023.
Bioreactors Market - https://exactitudeconsultancy.com/reports/29878/bioreactors-market/
The bioreactors market is expected to grow at 12.6% CAGR from 2023 to 2030. It is expected to reach above USD 24.24 billion by 2030 from USD 10.56 billion in 2023.
Elastography Imaging Market - https://exactitudeconsultancy.com/reports/29538/elastography-imaging-market/
The elastography imaging market is expected to grow at 11.30 % CAGR from 2022 to 2029. It is expected to reach above USD 11.17 billion by 2029 from USD 4.26 billion in 2020.
More Press Release sites:
https://bulletin.exactitudeconsultancy.com/
Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 sales@exactitudeconsultancy.com
© Copyright Globe Newswire, Inc. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Globe Newswire, Inc.
